[1]满枋霖,葛俊宏,林晓月,等.p21活化激酶在乳腺癌中的作用研究[J].医学信息,2019,32(06):35-37.[doi:10.3969/j.issn.1006-1959.2019.06.013]
　MAN Fang-lin,GE Jun-hong,LIN Xiao-yue,et al.The Role of p21 Activated Kinase in Breast Cancer[J].Journal of Medical Information,2019,32(06):35-37.[doi:10.3969/j.issn.1006-1959.2019.06.013]
点击复制

p21活化激酶在乳腺癌中的作用研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年06期
页码:
35-37
栏目:
综述
出版日期:
2019-03-15

文章信息/Info

Title:
The Role of p21 Activated Kinase in Breast Cancer
文章编号:
1006-1959（2019）06-0035-03
作者:
满枋霖1; 葛俊宏1; 林晓月2; 孙 新1
（1.北华大学医学院，吉林 吉林 132013；2.通化市中心医院，吉林 通化 134000）
Author(s):
MAN Fang-lin1; GE Jun-hong1; LIN Xiao-yue2; SUN Xin1
(1.School of Medicine,Beihua University,Jilin 132013,Jilin,China;2.Tonghua Central Hospital,Tonghua 134000,Jilin,China)
关键词:
p21活化激酶; 乳腺癌; PAKs
Keywords:
P21 activated kinase; Breast cancer; PAKs
分类号:
R737.9
DOI:
10.3969/j.issn.1006-1959.2019.06.013
文献标志码:
A
摘要:
乳腺癌是全球女性癌症患者中最常见的疾病，然而成功的治疗在临床上仍是一种挑战。近年来研究发现p21活化激酶家族成员与乳腺癌的发生发展有着密切的关系，因此，本文将对PAKs家族各成员与乳腺癌的关系进行简要综述。
Abstract:
Breast cancer is the most common disease among female cancer patients worldwide today. However, treatment it successfully is still a clinical challenge. In recent years, it was found that p21 activated kinase family members are closely related to the occurrence and development of breast cancer. Therefore, this paper will briefly review the relationship between PAKs and breast cancer.

参考文献/References:

[1]Zhang YC,Huo FC,Wei LL,et al.PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo[J].J Exp Clin Cancer Res,2017,36(1):146. [2]Dou Q,Chen HN,Wang K,et al.Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer[J].Cancer Res,2016,76(15):4457-4469. [3]Higgins MJ,Baselga J.Targeted therapies for breast cancer[J].The Journal of Clinical Investigation,2011,121(10):3797-3803. [4]Tabanifar B,Zhao Z,Manser E.PAK5 is auto-activated by a central domain that promotes kinase oligomerization[J].Biochem J,2016,473(12):1777-1789. [5]Man FL,Zhao LZ,Sun X.P21-activated Kinases (PAKs) and Their Role in Tomour[J].Chinese Journal of Biochemistry and Molecular Biolog,2015,31(6):579-585. [6]Wang X,Gong W,Qing H,et al.p21-activated kinase 5inhibits camptothecin-induced apoptosis in colorectal carcinomacells[J].Tumour Biol,2010,31(6):575-582. [7]Gonzalez N,Cardama GA,Comin MJ,et al.Pharmacological inhibition of Rac1-PAK1 axis restores tamoxifen sensitivity in human resistant breast cancer cells[J].Cellular Signalling,2017,30(12):154-161. [8]Zhan MN,Yu XT,Tang J,et al.MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1[J].Cell Death and Disease,2017,8(1):e2529. [9]Rider L,Shatrova A,Feener EP,et al.JAK2 Tyrosine Kinase Phosphorylates PAK1 and Regulates PAK1 Activity and Functions[J].Journal of Biological Chemistry,2007,282(42):30985-30996. [10]Hammer A,Rider L,Oladimeji P,et al.Tyrosyl phosphorylated PAK1 regulates breast cancer cell motility in response to prolactin through filamin A[J].Mol Endocrinol,2013,27(3):455-465. [11]Hammer A,Diakonova M.Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK dephosphorylation, breast cancer cell motility, invasion and metastasis[J].BMC Cell Biology,2016,17(1):31. [12]Li X,Wen W,Liu K,et al.Phosphorylation of caspase-7 by p21-activated protein kinase (PAK) 2 inhibits chemotherapeutic drug-induced apoptosis of breast cancer cell lines[J].J Biol Chem,2011,86(25):22291-22299. [13]Zhang Y,Wester L,He J,et al.IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer[J].Oncogene,2018,37(14):1869-1884. [14]Vershinin Z,Feldman M,Chen A,et al.PAK4 methylation by SETD6 promotes the activation of the Wnt/beta-catenin pathway[J].J Biol Chem,2016,291(13):6786-6795. [15]Li Y,Zhang H,Zhao Y,et al.A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells[J].Oncogene,2018,38(6):808-821. [16]He LF,Xu HW,Chen M,et al.Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling[J].Oncotarget,2017,8(11):17573-17585. [17]Rane C,Senapedis W,Baloglu E,et al.A novel orally bioavailable compound KPT-9274 inhibits PAK4,and blocks triple negative breast cancer tumor growth[J].Sci Rep,2017,7(2):42555. [18]Li Y,Ke Q,Shao Y,et al.GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling[J].Oncotarget,2015,6(6):4345-4356. [19]Wang XX,Cheng Q,Zhang SN,et al.PAK5-Egr1-MMP2 signaling controls the migration and invasion in breast cancer cell[J].Tumour Biol,2013,34(5):2721-2729. [20]宋锐,袁金金,侯歌,等.PAK6基因对人乳腺癌放疗敏感性及细胞凋亡影响及机制[J].中国老年学杂志,2018,38(11):2703-2706. [21]Liu W,Liu Y,Liu H,et al.Tumor suppressive function of p21-activated kinase 6 in hepatocellular carcinoma[J].J Biol Chem,2015,290(47):28489-28501.

相似文献/References:

[1]董 云.SPECT/CT 双时相99mTc- MIBI断层显像 在乳腺癌诊断中的应用[J].医学信息,2018,31(05):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
　DONG Yun.Application of SPECT/CT Dual-phase 99mTc-MIBI Tomography in the Diagnosis of Breast Cancer[J].Journal of Medical Information,2018,31(06):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
[2]张 虎,张 涛,徐 芳,等.MRI在乳腺癌诊治中的研究进展[J].医学信息,2022,35(10):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
　ZHANG Hu,ZHANG Tao,XU Fang,et al.Research Progress of MRI in Diagnosis and Treatment of Breast Cancer[J].Journal of Medical Information,2022,35(06):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
[3]李建辉,祝旭龙.乳腺癌的治疗管理——把好生活质量关[J].医学信息,2018,31(13):1.[doi:10.3969/j.issn.1006-1959.2018.13.001]
[4]杨玉峰,李 强,曲国红,等.乳腺癌术前巴德枪穿刺检测ER、PR的临床研究[J].医学信息,2018,31(13):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
　YANG Yu-feng,LI Qiang,QU Guo-hong,et al.Clinical Study on Preoperative ER and PR Detection of Bard Gun Puncture in Breast Cancer[J].Journal of Medical Information,2018,31(06):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
[5]刘雪静,路 红,徐熠琳,等.乳腺影像与容积导航技术初步应用的临床分析[J].医学信息,2022,35(11):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
　LIU Xue-jing,LU Hong,XU Yi-lin,et al.Clinical Analysis of the Preliminary Application of Breast Imaging and Volume Navigation Technology[J].Journal of Medical Information,2022,35(06):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
[6]刘在波,修文娟.背阔肌皮瓣联合假体在乳腺癌改良根治术后乳房重建中的应用[J].医学信息,2019,32(02):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
　LIU Zai-bo,XIU Wen-juan.Application of Latissimus Dorsi Flap Combined with Prosthesis in Breast Reconstruction after Modified Radical Mastectomy for Breast Cancer[J].Journal of Medical Information,2019,32(06):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
[7]孟庆国,王佳雪,王斯佳.马来酸吡咯替尼对乳腺癌术后患者心脏功能的影响[J].医学信息,2019,32(02):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
　MENG Qing-guo,WANG Jia-xue,WANG Si-jia.Effect of Pyrrolidine Maleate on Cardiac Function in Patients after Breast Cancer Operation[J].Journal of Medical Information,2019,32(06):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
[8]刘 曼,厉玛倩倩,徐润润,等.延续性护理对乳腺癌术后化疗患者生活质量与 健康知识水平的影响[J].医学信息,2018,31(16):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
　LIU Man,LIMA Qian-qian,XU Run-run,et al.Effect of Continuous Nursing on Quality of Life and Health Knowledge of Postoperative Chemotherapy Patients with Breast Cancer[J].Journal of Medical Information,2018,31(06):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
[9]张天竺,宁 勇.长链非编码RNA调控乳腺癌发生发展的研究进展[J].医学信息,2019,32(12):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]
　ZHANG Tian-zhu,NING Yong.Advances in Research on Long-chain Non-coding RNA Regulation of Breast Cancer Development[J].Journal of Medical Information,2019,32(06):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]
[10]苏 晓.乳腺癌的靶向药物治疗[J].医学信息,2019,32(12):46.[doi:10.3969/j.issn.1006-1959.2019.12.015]
　SU Xiao.Targeted Drug Therapy for Breast Cancer[J].Journal of Medical Information,2019,32(06):46.[doi:10.3969/j.issn.1006-1959.2019.12.015]

更新日期/Last Update: 2019-03-15